2seventy bio, Inc.
TSVTDelisted May 13, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001860782
2seventy bio, Inc. was delisted on May 13, 2025; its insiders filed their last Form 4 on May 15, 2025; 140 institutions reported holding it in 13F filings for Q1 2025, worth $234.5M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding 2seventy bio, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 134 | 3 | 142 | +11 |
| Shares | 33.9M | 93 | 33.5M | −431.8K (−1.3%) |
| Value | $493.6M | $1.25K | $317.3M | −$176.3M (−35.7%) |
3 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (30)
Institutions that held 2seventy bio, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (19)
Institutions that held 2seventy bio, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Armistice Capital, LLC | 1,264,000 | $18.4M |
| RTW Investments, LP | 1,229,508 | $17.9M |
| Sessa Capital IM, L.P. | 305,633 | $4.45M |
| Balyasny Asset Management LLC | 282,058 | $4.10M |
| Caas Capital Management LP | 228,245 | $3.32M |
| Altium Capital Management LP | 140,000 | $2.04M |
| Monashee Investment Management LLC | 70,000 | $1.02M |
| BNP Paribas Arbitrage, SA | 53,357 | $776.3K |
| Nan Fung Group Holdings Ltd | 40,273 | $586.0K |
| D. E. Shaw & Co., Inc. | 16,866 | $245.0K |
| Ensign Peak Advisors, Inc | 11,633 | $169.0K |
| Parametrica Management Ltd | 11,066 | $161.0K |
| Point72 Hong Kong Ltd | 3,688 | $54.0K |
| STRS Ohio | 1,600 | $23.0K |
| Macquarie Group Ltd | 332 | $6.00K |
| Lindbrook Capital, LLC | 93 | $1.00K |
| Howe & Rusling Inc | 17 | $0 |
| Loring Wolcott & Coolidge Fiduciary Advisors LLP | 123 | $0 |
| IFP Advisors, Inc | 152 | – |
Not filed for Q4 2022 yet (3)
Institutions that held 2seventy bio, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Wipfli Financial Advisors LLC, | 66 | $1.00K |
| American Portfolios Advisors | 17 | $247 |
| FourThought Financial, LLC | 10 | $0 |